Clinical Trial Update: An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

View source ↗

Summary

An observational study funded by Merck KGaA investigates the progression from clinically isolated syndrome to multiple sclerosis over two years, and the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Status: COMPLETED